The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Kidney Biopsy Global Market Report 2024, the kidney biopsy market is expected to show promising growth in the forecast period.

Market Growth and Projections

• Current Market Size and Growth: The kidney biopsy market has experienced substantial growth, expanding from $2.03 billion in 2023 to $2.14 billion in 2024. This growth represents a compound annual growth rate (CAGR) of 5.3%.
• Future Outlook: The market is projected to reach $2.66 billion by 2028, with a CAGR of 5.5%. Key drivers include an increase in kidney disease prevalence, rising healthcare expenditure, and heightened awareness about early diagnosis.

Key Growth Drivers

• Chronic Kidney Diseases: An increase in chronic kidney conditions is driving demand for biopsy procedures.
• Awareness and Early Diagnosis: Greater awareness about kidney health and early diagnosis is contributing to market growth.
• Aging Population: The surge in the geriatric population is leading to more cases of kidney diseases.
• Healthcare Infrastructure: Expansion in healthcare infrastructure supports more widespread availability of biopsy procedures.
• Government Initiatives: Enhanced government initiatives for kidney disease management are boosting market growth.

View More On The Kidney Biopsy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Technological Advancements

• Biopsy Techniques: Technological advancements are making biopsy techniques more effective and less invasive.
• Imaging Technologies: Innovations in imaging are improving the precision of kidney biopsies.
• Artificial Intelligence (AI): AI is enhancing diagnostic accuracy and streamlining procedures. For instance, Aiosyn’s NephroPath platform uses AI to analyze kidney biopsy histological biomarkers, improving consistency and detail in pathology assessments.

Role of Kidney Biopsy in Renal Cancer Detection

• Increased Renal Cancer Incidence: The rising incidence of renal cancer is a major driver for the kidney biopsy market. Factors include lifestyle changes, environmental toxins, and improved detection techniques.
• Diagnostic and Management Benefits: Kidney biopsies are crucial for diagnosing renal cancer, determining cancer grade, planning treatment, monitoring response, and providing prognostic information. According to Cancer Research UK, new kidney cancer cases are expected to increase significantly by 2025, further driving the market.

Major Companies and Market Players

• Leading Companies: Major players include Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., and many others.
• Acquisitions and Investments: Notable events include Halma plc’s acquisition of IZI Medical Products, which strengthens its position in the kidney biopsy sector and enhances the safety and accuracy of biopsy procedures.

Market Segmentation

• By Type: The market is divided into Percutaneous Biopsy and Surgical Biopsy.
• By Indication: Key indications include Kidney Failure, Kidney Transplant, Hematuria, and Proteinuria.
• By End-User: End-users comprise Hospitals and Clinics, Urology Centers, Tertiary Care Centers, and Other End-Users.

Regional Insights

• North America: The largest market for kidney biopsies in 2023.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period due to increasing healthcare investments and growing patient populations.

Conclusion
The kidney biopsy market is on a strong growth trajectory, driven by advancements in technology, rising disease prevalence, and expanding healthcare infrastructure. The integration of AI and strategic acquisitions are poised to further enhance market dynamics, ensuring more accurate and efficient biopsy procedures in the future.

Request A Sample Of The Global Kidney Biopsy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16458&type=smp